151
Rapport Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
310
FY25:
499
(positive)
Change from FY23 to FY25
millions USD
FY23:
4.55
FY24:
5.13
FY25:
13.9
Total assets
Change from FY23 to FY25
millions USD
FY23:
155
FY24:
315
FY25:
512
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
8.80
FY24:
8.77
FY25:
19.0
(negative)
Change from FY23 to FY25
millions USD
FY23:
5.68
FY24:
0.74
FY25:
8.73
(positive)
Change from FY23 to FY25
millions USD
FY23:
−25.6
FY24:
305
FY25:
485
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
315
FY25:
512
All amounts in millions USD